Therapy for acute nerve agent poisoning
- 1 August 2019
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Clinical Practice
- Vol. 9 (4), 337-342
- https://doi.org/10.1212/cpj.0000000000000641
Abstract
Purpose of review Acute nerve agent poisoning was last reviewed in the neurology literature in 2004. As neurologists may expect to be called upon by non-neurologist colleagues as local experts, it is timely to update the 2004 review. Recent findings Acute antidotal therapy for nerve agent poisoning has been rendered simpler and faster by the FDA approval and introduction of the dual-dose autoinjector. Although there are no truly new fielded antidotes, midazolam recently received FDA approval for treatment against seizures, and will replace diazepam in most acute situations when the FDA approves it in the autoinjector form. Information on acute therapy is much more easily accessed in real time now than in 2004, thanks to efforts by the National Library of Medicine and the American College of Medical Toxicology. Summary Since 2004, there have been changes in antidotal therapy and a robust expansion in familiarity with nerve agent management principles in the civilian sector. These advances are somewhat offset by the increased use of nerve agents for nefarious purposes.Keywords
This publication has 11 references indexed in Scilit:
- Novichok agents: a historical, current, and toxicological perspectiveToxicology Communications, 2018
- Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory networkForensic Toxicology, 2017
- Pre-hospital midazolam for benzodiazepine-treated seizures before and after the Rapid Anticonvulsant Medication Prior to Arrival Trial: A national observational cohort studyPLOS ONE, 2017
- Lessons Learned From the Syrian Sarin Attack: Evaluation of a Clinical Syndrome Through Social MediaAnnals of Internal Medicine, 2014
- RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedicsEpilepsia, 2011
- Further evidence that pathologic high-frequency oscillations are bursts of population spikes derived from recordings of identified cells in dentate gyrusEpilepsia, 2011
- Case report: Long-term cognitive sequelae of sarin exposureNeuroToxicology, 2010
- The birth of nerve agent warfareNeurology, 2004
- Therapy for Nerve Agent PoisoningArchives of Neurology, 2004
- A Viable Neuroprotection Strategy Following Soman-induced Status EpilepticusPublished by Defense Technical Information Center (DTIC) ,2003